查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1629776

中東和非洲的泡殼包裝：市場佔有率分析、產業趨勢和成長預測（2025-2030）

MEA Blister Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

中東和非洲泡殼包裝市場預計在預測期內複合年成長率為 5.2%

MEA吸塑包裝-市場-IMG1

主要亮點

  • 泡殼包裝是用於小型消費品、食品和藥品的幾種預成型塑膠包裝的總稱。這些包裝解決方案有助於長期保護產品免受潮濕和污染等外部因素的影響。不透明泡殼還可保護光敏產品免受紫外線傷害。如此廣泛的應用使其在市場上具有吸引力。
  • 疾病發病率的上升和政府對假藥的嚴格監管正在促使製藥公司超越維持其生產目的的功效的基本需求，生產包裝清晰且難以模仿的藥品，其中之一就是不斷增加的需求壓力。關鍵因素。泡殼包裝為鈔票認證系統等防偽系統提供了有效的方法。
  • 隨著製造商、消費者和監管機構對產品安全的需求增加，泡殼包裝正成為越來越實用的選擇。產品完整性和延長保存期限等因素對於製藥業非常重要，因為大多數消費者將藥品儲存在高溫波動的環境中，這可能對未受保護的藥品有害。
  • 遵守安全法規的需求不斷成長，加上對方便易用的包裝產品的需求不斷成長，正在推動所研究市場的成長，導致市場供應商與科技公司合作來實現這些功能。產品差異化優勢。
  • 此外，環保泡殼包裝在該地區越來越受歡迎。例如，Sonoco 提供 EnviroSense，一種用於零售包裝的紙泡殼，作為塑膠泡殼包裝的替代品。該公司還計劃在 2025年終減少塑膠的使用。

中東和非洲泡殼包裝市場趨勢

藥品預計將顯著成長

  • 製藥業對泡殼包裝解決方案提出了不同的要求，例如與外部環境隔離、成本效益、高防護性、易於處理和保存藥效等。這些包裝特別適合滿足嚴格的法規，並因其保護性能、成本效益、適應性以及製藥和包裝行業的需求而受到重視。
  • 當藥物包裝在泡殼包裝中時，消費者知道他們的藥物和劑量，從而提高用藥依從性。泡殼的單位劑量特徵降低了錯誤劑量的風險。
  • 零售層面的處方藥製備對於製藥技術人員和藥劑師來說是一個挑戰。在超級市場和藥局的開放環境中給藥可能會對敏感藥物在容器之間轉移時產生不利影響。泡殼包裝可以確保直接配送給客戶。
  • 雖然保護產品完整性仍然是藥品包裝的首要目標，但包裝產業的所有領域都在繼續努力降低包裝過程中的成本。
  • 例如，Amcor 的 Polybar 阻隔薄膜系列涵蓋廣泛的防潮阻隔性，具有出色的抗壓性能，可確保為錠劑和膠囊等製藥應用提供最佳保護。我們使用 Aclar、COC、PE、PVC 和 PVdc 等材料。
  • 然而，由於 COVID-19 的影響導致供應鏈中斷，2020 年整個非洲的藥品出口下降。例如，根據 Trade Map，摩洛哥的藥品出口額從 2019 年的 1.1708 億美元降至 2020 年的 1.099 億美元。

非洲佔最大市場佔有率

  • 該國的泡殼包裝廣泛用於封裝各 CMO 供應商生產的 API。在中東和非洲地區，南非被譽為非洲最大的CMO市場之一。南非醫藥契約製造具有吸引力的主要因素是其成熟、穩定的市場和較高的投資周轉率。
  • 對於想要進入市場的外國公司來說，稅收和關稅可能是一個挑戰。同時，政府支持的增加、醫療保健支出的增加以及支持藥物配方創新的舉措以及對藥品的興趣預計將擴大該國的商機。
  • 此外，奈及利亞是西非最有前景、成長最快的藥品生產地區之一，擁有 150 多個藥品製劑生產設施。藥品契約製造的主要成長要素是成本優勢、生物製藥需求的增加、政府法規和專利到期。

中東和非洲泡殼包裝產業概況

中東和非洲泡殼包裝產業高度集中。夥伴關係、併購和收購已成為市場上供應商生產最終用戶行業可接受的產品的重要策略，其中包裝材料經過嚴格的品質檢查，以確保它們不會污染內容物並影響健康。維持原料的持續流動仍是促進夥伴關係的挑戰。市場的主要參與者包括 Amcor Ltd、Sonoco Products Company、Constantia Flexibles GmbH 和 Honeywell International Inc.。

  • 2021 年 4 月 - Amcor 宣布對可回收聚乙烯基熱成型泡殼包裝進行客戶試驗。這種新包裝旨在滿足高度專業化和監管的藥品包裝的嚴格要求，為最受歡迎的醫療保健包裝類型創造更永續的選擇。與市場上的替代包裝相比，這種創新包裝可減少高達 70% 的碳足跡。
  • 2021 年 7 月 - Futamaki 為醫療保健產業推出紙質泡殼包裝「Push Tab」。該公司使用的紙張經過 FSC 認證，可取代由熱成型 PVC 或鋁製成的傳統推入式包裝，從而減少整個價值鏈對環境的影響。

其他好處：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

目錄

第1章簡介

  • 研究假設和市場定義
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場洞察

  • 市場概況
  • 市場促進因素
    • 老年人口增加和疾病傳播
    • 產品創新，例如相對便宜的小型化
  • 市場挑戰
    • 法規的動態性和缺乏處理重載的能力
  • 產業吸引力－波特五力分析
    • 供應商的議價能力
    • 消費者議價能力
    • 新進入者的威脅
    • 競爭公司之間敵對關係的強度
    • 替代品的威脅
  • 評估 COVID-19 對泡殼包裝市場的影響

第5章市場區隔

  • 按流程
    • 熱成型
    • 冷成型
  • 按材質
    • 塑膠薄膜
    • 紙板
    • 鋁
    • 其他材料
  • 按最終用戶產業
    • 消費品
    • 藥品
    • 工業的
    • 其他最終用戶產業
  • 按國家/地區
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 中東及非洲其他地區

第6章 競爭狀況

  • 公司簡介
    • Amcor PLC
    • MTS Medication Technologies
    • Constantia Flexibles GmbH
    • Sonoco Products Company
    • Klockner Pentaplast Group
    • Du Pont De Nemours and Company
    • Honeywell International Inc.
    • The Dow Chemical Company

第7章 投資分析

第8章市場的未來

簡介目錄
Product Code: 56488

The MEA Blister Packaging Market is expected to register a CAGR of 5.2% during the forecast period.

MEA Blister Packaging - Market - IMG1

Key Highlights

  • Blister pack is a term for several types of pre-formed plastic packaging used for small consumer goods, foods, and pharmaceuticals. These packaging solutions are useful for protecting products against external factors, such as humidity and contamination, for extended periods of time. Opaque blisters also protect light-sensitive products against UV rays. Such a wide base of applications has helped it gain traction in the market.
  • Increasing pressure on pharmaceutical companies to manufacture medicines that are distinct in packaging and hard to imitate, beyond the basic need of keeping it effective for the purpose it was produced, for it to be made available for patients, owing to rise in diseases and stringent government regulations against counterfeit drugs, are among the major factors propelling the market. Blister packaging offers an efficient method of anti-counterfeit systems, like banknote authentication systems and others.
  • The rising need for a level of product safety from manufacturers, consumers, and regulatory organizations makes blister packaging an increasingly practical option. Factors like product integrity and extended shelf life are highly necessary for the pharmaceutical sector, considering that most consumers store their drugs in a temperature variant atmosphere that can be harmful to unprotected medicines.
  • The growing need for compliance with safety regulations, coupled with increased demand for convenient and easy-to-use packaging products, is also expected to drive the growth of the market studied and result in the market vendors partnering with technology companies to introduce those features and widen their product differentiation advantages for bulk purchasers.
  • Moreover, the region is witnessing traction for eco-friendly blister packaging. For example, Sonoco offers EnviroSense, a paper blister for retail packaging, and is designed as an alternative to plastic blister packages. Additionally, with this, the comany has aimed to reduce the use of plastic by the end of 2025

MEA Blister Packaging Market Trends

Pharmaceutical is Expected to Witness a Significant Growth

  • The pharmaceutical sector poses a different set of demands for blister packaging solutions, concerning insulation from external surroundings, cost-effectiveness, high levels of protection, and the ease of handling and retaining the effectiveness of the medicine. These packs are uniquely suited to meet stringent regulations and are highly valued for protective properties, cost-effectiveness, adaptability, and the pharmaceutical and packaging industry's requirements.
  • When medicines are blister packaged, adherence is improved because consumers can keep track of their medications and dosage. The unit dosage feature of blisters reduces the risk of incorrect dosing.
  • The retail-level preparation of prescription drugs is troubling pharmaceutical technicians or pharmacists. The administration of medicines in the open atmosphere of the supermarket and drug store may negatively affect sensitive medicines when they are transferred from container to container. Blister packaging can guarantee the process of distribution directly to the customer.
  • Protecting product integrity continues to be the primary goal of pharmaceutical packaging, but there is continued work on cost reduction in the packaging process in all areas of the packaging industry.
  • For Example, The Polybar barrier films product families provided by Amcor cover a wide range of moisture barriers whilst also providing good crush resistance to ensure the best protection for pharmaceutical applications such as tablets and capsules. It uses materials such as Aclar, COC, PE, PVC, and PVdc, among others.
  • However, due to the supply chain disruption caused due to the impact of COVID-19, the exports of pharmaceutical products decreased across Africa in 2020. For instance, according to Trade Map, the value of pharmaceutical products exported from Morocco reduced to USD 109.9 million in 2020 compared to USD 117.08 million in 2019.

Africa to hold the Largest Market Share

  • Blister packaging in the country is widely used to contain the APIs manufactured by various CMO vendors. In the MEA region, South Africa is known as one of the largest CMO markets in Africa. Some of the major factors responsible for South Africa's attractive pharmaceutical contract manufacturing are its well-established and stable markets and high turnover to investments.
  • The tax structures and duties are possible challenges for foreign companies that aim to enter the market. On the other hand, increasing governmental support, rising health expenditure, and initiatives taken to support innovations in drug formulation and pharmaceutical interest are expected to bolster the opportunities available in the country.
  • Moreover, Nigeria is one of the most promising and rapidly growing pharmaceutical manufacturing regions in West Africa, with more than 150 pharmaceutical formulation manufacturing facilities. The major drivers of growth in pharmaceutical contract manufacturing are cost advantage, increased demand for biological production, government regulations, and patent expiry.

MEA Blister Packaging Industry Overview

The Middle East and Africa Blister Packaging are highly concentrated. Partnership, mergers, and acquisitions have been a significant strategy for the vendors in the market for producing products that are acceptable in the end-user industry, where packaging materials undergo stringent quality tests not to contaminate the contents impact health. Maintaining a continuous flow of raw materials remain a challenge that prompts partnerships. Some of the major players in the market are Amcor Ltd, Sonoco Products Company, Constantia Flexibles GmbH, Honeywell International Inc., among others.

  • April 2021- Amcor announced customer trials for recyclable Polyethylene-based thermoform blister packaging. The new packaging is designed to meet the stringent requirements of highly specialized and regulated pharmaceutical packaging and creates a more sustainable alternative for the most in-demand healthcare packaging type. This innovation also benefits from up to 70% reduction in its carbon footprint when compared to packaging alternatives on the market.
  • July 2021 - Huthamaki launched Push Tab paper-based blister solution for the healthcare industry. The paper used by the comany is FSC certified and acts as an alternative to traditional push-through packaging made of thermoformed PVC and aluminum, thus reducing the environmental impact across the value chain.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing geriatric population and prevalence of diseases
    • 4.2.2 Product innovations such as downsizing coupled with relatively low costs
  • 4.3 Market Challenges
    • 4.3.1 Dynamic nature of regulations and inability to support heavy goods
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Intensity of Competitive Rivalry
    • 4.4.5 Threat of Substitutes
  • 4.5 Assessment of the impact of COVID-19 on Blister Packaging Market

5 MARKET SEGMENTATION

  • 5.1 By Process
    • 5.1.1 Thermoforming
    • 5.1.2 Coldforming
  • 5.2 By Material
    • 5.2.1 Plastic Films
    • 5.2.2 Paper and Paperboard
    • 5.2.3 Aluminum
    • 5.2.4 Other Materials
  • 5.3 By End-User Industry
    • 5.3.1 Consumer Goods
    • 5.3.2 Pharmaceutical
    • 5.3.3 Industrial
    • 5.3.4 Other End-User Industries
  • 5.4 By Country
    • 5.4.1 Saudi Arabia
    • 5.4.2 United Arab Emirates
    • 5.4.3 South Africa
    • 5.4.4 Other Regions in Middle East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Amcor PLC
    • 6.1.2 MTS Medication Technologies
    • 6.1.3 Constantia Flexibles GmbH
    • 6.1.4 Sonoco Products Company
    • 6.1.5 Klockner Pentaplast Group
    • 6.1.6 Du Pont De Nemours and Company
    • 6.1.7 Honeywell International Inc.
    • 6.1.8 The Dow Chemical Company

7 INVESTMENT ANALYSIS

8 FUTURE OF THE MARKET